Premature LH and progesterone rise in intrauterine insemination cycles: Analysis of related factors

Reproductive BioMedicine Online

Volumn 7, Issue 2, 2003, Pages 194-199

  Cunha Filho, João Sabino ^a   Kadoch, Jacques ^a   Righini, Claudia ^a   Fanchin, Renato ^a   Frydman, René ^a   Olivennes, François ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Intrauterine insemination; LH rise; Premature luteinization; Progesterome increase

Indexed keywords

CLOMIFENE; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; HORMONAL REGULATION; HUMAN; INTRAUTERINE INSEMINATION; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE; PREDICTION; PROGESTERONE BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0141851012     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61751-8     Document Type: Article

References (26)

1. Albano C, Smitz J, Camus M et al. 1997 Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertility and Sterility 67, 917-922.
2. Borm G, Mannaerts B 2000 Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Human Reproduction 15, 1490-1498.
3. Cahill DJ, Wardle PG, Harlow CR, Hull MGR. 1998 Onset of the preovulatory luteinizing hormone surge: diurnal timing and critical follicular prerequisites. Fertility and Sterility 70, 56-59.
4. Cahill DJ, Wardle PG, Harlow CR et al. 2000 Expected contribution to serum estradiol from individual ovarian follicles in unstimulated cycles. Human Reproduction 15, 1909-1912.
5. Christin-Maitre S, Olivennes F, Dubourdieu S et al. 2000 Effect of GnRH antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation. Clinical Endocrinology 52, 721-726.
6. Costello MF, Hughes GJ, Garret DK et al. 1998 A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization. International Journal of Fertility 43, 28-33.
7. Couzinet B, Schaison G 1993 The control of gonadotrophin secretion by ovarian steroids. Human Reproduction 8, 97-101.
8. De Boever J, Kohen F, Vandekerckhove D 1983 Solid-phase chemiluminescence immunoassay for plasma estradiol-17 beta during gonadotropin therapy compared with two radioimmunoassays. Clinical Chemistry 29, 2068-2072.
9. Eibschitz I, Belaisch-Allart JC, Frydman R 1986 In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge. Fertility and Sterility 45, 231-236.
10. Eissa MK, Obhrai MS, Docker MF et al. 1986 Follicular growth and endocrine profiles and induced conception cycles. Fertility and Sterility 45, 191-195.
11. Fanchin R, Righini C, Olivennes F et al. 1996 Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertility and Sterility 65, 1178-1183.
12. Fowler PA, Templeton A, Messinis IE 1993 The ovarian modulation of gonadotrophin releasing hormone-induced luteinizing hormone secretion on women. Human Reproduction 8, 112-116.
13. Fowler PA, Sorsa T, Harris WJ et al. 2001 Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women. Human Reproduction 16, 1353-1358.
14. Freimanis MG, Jones AF 1992 Transvaginal ultrasonography. Radiolic Clinics of North America 30, 955-976.
15. Fuh KW, Wang X, Tai A et al. 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and insemination on pregnancy rates. Human Reproduction 12, 2162-2166.
16. Gougeon A, Lefevre B 1983 Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle. Journal of Reproductive Fertility 69, 497-502.
17. Hershlag A, Zinger M, Lesser M et al. 2000 Is chemiluminescent immunoassay an appropriate substitution for radioimmunoassay in monitoring estradiol levels? Fertility and Sterility, 73 1174-1178.
18. Kagawa T, Yamano S, Nishida S et al. 1992 Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). Journal of Assisted Reproduction and Genetics, 9 106-112.
19. Kreiner D, Droesch K, Itskovitz J et al. 1988 Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol and follicle stimulating hormone in in vitro fertilization and embryo transfer. Journal of In Vitro Fertilization and Embryo Transfer 5, 265-267.
20. Loumaye E 1990 The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in vitro fertilization and embryo transfer. Human Reproduction 5, 357-376.
21. McCartney CR, Gingrich MB, Hu Y et al. 2002 Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone. Journal of Clinical Endocrinology and Metabolism 87, 2194-2200.
22. Macnamee MC, Edwards RG, Howles CM 1988 The influence of stimulation regimes and luteal phase support on the outcome of IVF. Human Reproduction 3 (suppl. 2), 43-52.
23. Olivennes F, Alvarez S, Bouchard P et al. 1998 The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Human Reproduction 13, 2411-2414.
24. Taylor AE, Whitney H, Hall JE et al. 1995 Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. Journal of Clinical Endocrinology and Metabolism 80, 1541-1547.
25. Testart J, Frydman R. 1982 Minimum time lapse between luteinizing hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertility and Sterility 37, 50-53.
26. Testart J, Frydman R, Roger M 1982 Seasonal influence of diurnal rhythms in the onset of the plasma luteinizing hormone surge in women. Journal of Clinical Endocrinology and Metabolism 55, 374-377.